Last reviewed · How we verify
B12019 and Neulasta — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
B12019 and Neulasta (B12019 and Neulasta) — Cinfa Biotech.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| B12019 and Neulasta TARGET | B12019 and Neulasta | Cinfa Biotech | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- B12019 and Neulasta CI watch — RSS
- B12019 and Neulasta CI watch — Atom
- B12019 and Neulasta CI watch — JSON
- B12019 and Neulasta alone — RSS
Cite this brief
Drug Landscape (2026). B12019 and Neulasta — Competitive Intelligence Brief. https://druglandscape.com/ci/b12019-and-neulasta. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab